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Multiple primary cutaneous plasmacytoma: 
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Abstract: Primary cutaneous plasmacytoma is a rare disease characterized by monoclonal proliferation of
plasma cells in the skin, in the absence of bone or systemic disease. It can be solitary or multiple, the lat-
ter being even more rare and presenting a higher mortality rate. We describe the clinical, histopathologi-
cal and immunohistochemical  aspects as well as the evolution of an 87-year-old female patient, diagnosed
as having multiple primary cutaneous plasmacytomas.
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Resumo: O plasmocitoma cutâneo primário é uma entidade rara, caracterizada pela proliferação mono-
clonal de plasmócitos na pele, na ausência de doença óssea ou sistêmica. Pode ser único ou múltiplo,
sendo esta última forma ainda mais rara e de pior prognóstico. Descreveremos os aspectos clínicos, histo-
patológicos, imunohistoquímicos e a evolução de um caso de paciente do sexo feminino, 87 anos, com
diagnóstico de plasmocitoma cutâneo primário com múltiplas lesões. 
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INTRODUCTION
A plasmacytoma is a malignant tumor character-
ized by proliferation of monoclonal plasma cells. The
primary involvement of the skin without evidence of
systemic or bone disease is extremely rare.1,2,3
According to the classification of skin lymphomas,
approved in 2005 by the World Health Organization-
European Organization for Research and Treatment of
Cancer (WHO-EORTC), extramedullary plasmacy-
tomas of the skin are nowadays included within the
group of primary cutaneous marginal-zone B-cell lym-
phoma.4 We describe the first reported case of multi-
ple primary cutaneous plasmacytoma in Brazil.
CASE REPORT
An 87-year-old female presented with a six-
month history of painless, disseminated erythema-
tous-violaceous papules and plaques, well circum-
scribed, measuring 0.5 to 2.5 cm on the chest,
629CASE REPORT
An Bras Dermatol. 2012;87(4):629-31.
abdomen, upper and lower extremities (Figure 1).
Her past medical history included classic Kaposi’s sar-
coma (CD 34 and Human Herpes Virus 8 were posi-
tive in tumor cells on immunohistochemical analysis),
which was treated with radiotherapy in 1993, and
Alzheimer’s disease since 1999.
Skin biopsy demonstrated diffuse proliferation
of plasma cells in superficial and deep dermis (Figure
2). On immunohistochemical analysis for kappa and
lambda, light chain restriction was demonstrated with
a ratio of kappa/lambda 7:1 confirming the monoclon-
al nature of the plasma cells, which were also positive
for CD138 (Figure 3).
The patient underwent screening laboratory
tests (blood cell count, creatinine, calcium,
immunoglobulins, urine), skeletal exams and bone
marrow biopsy. All data collected excluded the possi-
bility of multiple myeloma and supported the diagno-
sis of multiple primary cutaneous plasmacytoma.
Considering the patient’s age, comorbidities
and lack of change in quality of life, the option of
delaying chemotherapy was preferred. After 12
months of rigorous follow-up the patient showed no
signs of systemic disease.
DISCUSSION
Cutaneous plasmacytoma can either present as
a primary or a secondary tumor. The most common in
primary presentation is the solitary plasmacytoma of
the bone, originally from the bone marrow. The pri-
mary extramedullary forms occur in the upper respi-
ratory tract, gastrointestinal tract, lymphoreticular sys-
tem and skin, in absence of systemic disease. The sec-
ondary forms result from hematogenic systemic dis-
ease, the multiple myeloma, or extending directly
from the bone lesions.1,5,6,7 The mean age of the
patients is 59.5 years, with male predominance.2,7
Clinically, the lesions are erythematous-viola-
ceous cutaneous or subcutaneous papules, plaques
and/or nodules, with a smooth-surface, ranging from
1 to 5 cm in diameter. Ulceration of the lesions is
rarely observed. The tumor can be solitary or multi-
ple, most commonly found on the face, trunk and
extremities.1,4,5,7
Histologically, a dense monomorphic plasma-
cytic infiltrate is found in the superficial dermis, pos-
sibly involving the reticular dermis and subcutaneous
tissue. Atypia, binucleation and increase in the mithot-
ic activity can be present in plasma cells.1,5,7 The epi-
dermis is generally spared. Immunohistochemistry
allows to distinguish reactive plasma-cell proliferation
by infections, inflammatory processes or other neo-
plasms (plasmacytosis) from monoclonal plasma cell
proliferation (plasmacytoma).5,8 A positive CD138,
CD79a and CD38 supports plasma cell lineage. CD20
is typically negative. The plasmacytoma displays clon-
al kappa or lambda light chains, as a marker of malig-
nancy.1,5,9
The preferred mode of therapy in the case of
solitary lesions is surgical excision, local radiotherapy
or the combination of both. Systemic chemotherapy is
FIGURE 1: Disseminated erythematous-violaceous papules and
 plaques
FIGURE 2: Light microscopy with diffuse proliferation of plasma
cells in superficial and deep dermis  (HE100x/HE400x)                                                                                         
FIGURE 3: Immunohistochemical analysis for kappa and lambda,
light chain restriction was demonstrated with a ratio of
kappa/lambda 7:1 (400x)
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indicated in patients with multiple lesions.1,2,5,9
Very few cases were described in the literature,
therefore it is challenging to evaluate the risks of the
transformation to a systemic disease, although it is
known that the risks are higher in patients with exten-
sive and multiple lesions, explaining the worse prog-
nosis and higher mortality rate described in this
group.2,3,7,9,10 Follow up in these cases must be rigorous
with appropriate and efficient treatment in case the
disease evolves into a multiple myeloma.1 q
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